These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9869112)

  • 1. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia.
    Heal G; Elwood RK; FitzGerald JM
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):979-83. PubMed ID: 9869112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco.
    White MC; Gournis E; Kawamura M; Menendez E; Tulsky JP
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):30-5. PubMed ID: 12701832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW; Morse MM; Pape JW; Johnson WD
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
    Batki SL; Gruber VA; Bradley JM; Bradley M; Delucchi K
    Drug Alcohol Depend; 2002 May; 66(3):283-93. PubMed ID: 12062463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directly observed isoniazid preventive therapy for released jail inmates.
    Nolan CM; Roll L; Goldberg SV; Elarth AM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):583-6. PubMed ID: 9032198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children.
    van Zyl S; Marais BJ; Hesseling AC; Gie RP; Beyers N; Schaaf HS
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):13-8. PubMed ID: 16466031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INH preventive therapy among adult HIV-infected patients in Thailand.
    Hiransuthikul N; Nelson KE; Hiransuthikul P; Vorayingyong A; Paewplot R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):270-5. PubMed ID: 15786889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive therapy for tuberculosis in Western Australia.
    Pang SC; Harrison RH; Brearley J; Jegathesan V; Clayton AS
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):984-8. PubMed ID: 9869113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.